(Q46985569)
Statements
1 reference
rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses (English)
1 reference
B Graham
1 reference
P Bart
1 reference
Y Huang
1 reference
N Frahm
1 reference
S Karuna
1 reference
M Allen
1 reference
NK Kochar
1 reference
S Chappuis
1 reference
J Gaillard
1 reference
G Pantaleo
1 reference
13 September 2012
1 reference
1 reference
9
1 reference
Suppl 2
1 reference
O72-O72
1 reference
1 September 2012
1 reference
Identifiers
1 reference
1 reference